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Surviving infection represents a balance between the
proinflammatory responses needed to eliminate the
pathogen, and anti-inflammatory signals limiting
damage to the host. IL-10 is a potent immunosup-
pressive cytokine whose impact is determined by
the timing and localization of release. We show that
NK cells rapidly express IL-10 during acute infection
with diverse rapidly disseminating pathogens. The
proinflammatory cytokine IL-12 was necessary and
sufficient for NK cell induction of IL-10. NK cells
from mice with systemic parasitic infection inhibited
dendritic cell release of IL-12 in an IL-10-dependent
manner, and NK cell depletion resulted in elevated
serum IL-12. These data suggest an innate, negative
feedback loop inwhich IL-12 limits its ownproduction
by eliciting IL-10 fromNK cells. In contrast to dissem-
inatingpathogens, locally restricted infectionsdidnot
elicit NK cell IL-10. Thus systemic infections uniquely
engageNK cells in an IL-10-mediated immunoregula-
tory circuit that functions to alleviate inflammation.INTRODUCTION
Surviving infection requires a precise balance between the proin-
flammatory immune response needed to eliminate the pathogen,
and anti-inflammatory signals essential to limit collateral damage
to the host. Sepsis is a clinical example of the consequence
when this balance is lost: the widespread immune activation
associated with uncontrolled dissemination of a pathogen can
result in systemic inflammation, multiorgan failure, and death
(Cohen, 2002). IL-10 is a potent immunosuppressive cytokine
that provides one mechanism of counterregulation, and in
diverse models of infection IL-10 is critical for the maintenance
of immune balance (Couper et al., 2008). During acute toxoplas-
mosis, for example, rapid production of proinflammatory inter-
feron (IFN)-g is essential to control the parasite (Suzuki et al.,
1988) but IL-10-deficient mice die with increased intestinal and
liver pathology, despite a reduced parasite burden (Gazzinelli
et al., 1996; Suzuki et al., 2000).Cell Host &Several cellular sources of IL-10 have been identified and in
infectious diseases attention has focused on CD4+ T cells in
lymphoid organs (Anderson et al., 2007; Jankovic et al., 2007;
Li and Flavell, 2008; Roers et al., 2004). These cells, however,
release cytokines only during the adaptive phase of immune
responses, concomitant with the expression of potent effector
functions. Potential sources of earlier IL-10 production include
B cells and innate cells such as macrophages and dendritic cells
(Corinti et al., 2001; Fillatreau et al., 2002; Katakura et al., 2004).
Even NK cells, which are best known for their innate release of
IFN-g, can be stimulated to secrete IL-10 in vitro (Chakir et al.,
2001; Deniz et al., 2008; Mehrotra et al., 1998) and, in both
humans and mice, this activity has been associated with immu-
nosuppression (De Maria et al., 2007; Maroof et al., 2008).
However, the relative contribution of NK cells to the expression
of IL-10 and the factors that elicit NK cell-derived IL-10 in vivo
are still unknown.
To examine the sources of IL-10 during infection with diverse
pathogens, we analyzed its expression in vivo using both wild-
type mice and IL-10 reporter animals. We reveal that NK cells
are the first and the most frequent IL-10-expressing population
induced in nonlymphoid tissues during acute, systemic infection.
NK cell release of IL-10 is elicited by IL-12, and it acts via
negative feedback to inhibit the pathogen-stimulated production
of IL-12 by dendritic cells. This regulatory circuit is specific
to systemic inflammation and is not engaged by the limited
IL-12 signaling that occurs during localized infections. NK
cells therefore appear to offer an IL-10-mediated, immunosup-
pressive capacity that is rapidly activated in situations of
systemic insult. Thus the dissemination of a pathogen directs
qualitative changes in the cellular response mounted by the
infected host.
RESULTS
NK Cells Express IL-10 upon Infection
with Diverse Pathogens
To identify the sources of IL-10 during acute infection, we in-
fected bicistronic IL-10-GFP reporter mice, designated Vert-X
(Madan et al., 2009; Sun et al., 2009), with the rapidly dissemi-
nating, protozoan pathogen T. gondii. Consistent with data ob-
tained in this and other IL-10 reporter mice (Kamanaka et al.,
2006; Maynard et al., 2007), and elsewhere (Jankovic et al.,Microbe 6, 503–512, December 17, 2009 ª2009 Elsevier Inc. 503
Figure 1. NK Cells Are the First and
Predominant IL-10-Expressing Population
in Acute Toxoplasmosis
Vert-X IL-10 reporter mice were infected with
T. gondii and, 7 days later, the indicated lympho-
cyte populations analyzed by flow cytometry.
Sham-infected Vert-X mice were analyzed for
comparison.
(A) Liver cells were stained to distinguish lympho-
cyte subsets. Numbers indicate the percentage
of GFP-positive cells within each population,
rounded to the nearest full digit.
(B) Lymphocytes from various tissues were as-
sessed for NK1.1 and IL-10. Infected nonreporter
mice were included to control for autofluores-
cence.
(C) NK1.1-gated cells were stained with TCRb to
discriminate NK and NK T cells.
(D) NK cells (NK1.1+TCRb) were sorted from
the livers of T. gondii-infected nonreporter mice.
IL-10 expression was determined by RT-PCR and
is shown as fold induction over sham-infected
controls.
(E) Cells were isolated as in (D), and IL-10 protein
production was measured after stimulation with
PMA and ionomycin. Error bars indicate SD of
triplicate cultures.
(F) Vert-X mice were bled at various times postin-
fection, and GFP expression within the indicated
populations was quantified by flow cytometry.
Data depict the mean of three mice ±SD.
(G) Vert-X mice were infected with T. gondii and, on
day 7, the total numbers of GFP+ NK1.1+ TCRb
(NK) and GFP+ CD4+ (CD4) cells calculated per
organ or per milliliter of blood. Data depict the
mean of three mice ±SD. All panels are representa-
tive of two or more independent experiments.
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absent in sham-infected or naive animals (Figures 1A and 1B
and data not shown) and was detected in CD4+ T cells 1 week
after infection with T. gondii (Figure 1A). IL-10 expression was
also apparent in CD8+ T cells, CD19+ B cells, and NK T cells
(NK1.1+TCRb+) (Figure 1A). Most strikingly, 75% ± 11% (mean ±
SD) of NK cells (NK1.1+TCRb) in the liver and 84% ± 6% in the
blood also acquired an IL-10-GFP+ phenotype (Figures 1A–1C504 Cell Host & Microbe 6, 503–512, December 17, 2009 ª2009 Elsevier Inc.and 1F). Similar data were obtained after
intraperitoneal infection with T. gondii
(see Figure S1 available online). NK1.1+
GFP+ cells were present in all analyzed
tissues and, although rare in the spleen
and mesenteric lymph node, were the
predominant IL-10+ population in non-
lymphoid organs (Figure 1B). The
majority of NK1.1+GFP+ cells did not
stain for TCRb (Figure 1C) or CD33 (data
not shown), identifying them as NK cells
rather than NK T cells or conventional
T cells expressing NK1.1 upon activation
(Slifka et al., 2000). RT-PCR analysis of
WT C57BL/6 and Rag/ nonreporter
mice confirmed the contribution of innateimmune cells to the expression of IL-10 during infection
(Figure S2). Indeed, NK cells sorted from T. gondii- but not
sham-infected WT C57BL/6 mice showed clear induction of
IL-10 in NK cells, both by RT-PCR (Figure 1D) and by IL-10
protein production upon ex vivo stimulation (Figure 1E). Kinetic
studies in Vert-X mice revealed that NK cell IL-10 expression
was initiated between 3 and 4 days after infection, preceding
the induction of IL-10 in CD4+ T cells (Figure 1F). IL-10+ NK cells
Figure 2. NK Cell IL-10 Is Elicited by Systemic Inflammation
(A) Vert-X mice were infected with T. gondii, L. monocytogenes, or Y. pestis
and analyzed by flow cytometry 7, 4, and 4 days later, respectively, together
with sham-infected controls.
(B) CpG or LPS was given to Vert-X mice i.v. in PBS, and recipients were
analyzed 48 hr later. In both panels, data shown are gated on NK cells from
peripheral blood and are representative of three to five mice per group in at
least two independent experiments.
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liver of T. gondii-infected mice, while their numbers were similar
in the spleen (Figure 1G). Thus, NK cells represented an early IL-
10-expressing population during toxoplasmosis and were the
predominant IL-10+ population in nonlymphoid tissues at the
peak of the acute inflammatory response.
To determine whether other pathogens besides T. gondii also
elicit NK cell IL-10, Vert-X mice were inoculated with two distinct,
rapidly disseminating bacteria and their NK cells analyzed 4 days
later (Figure 2A). After infection with the gram-positive bacterium
Listeria monocytogenes, 79% ± 11% of blood NK cells became
GFP positive. Likewise, infection with the gram-negative bacte-
rium Yersinia pestis elicited IL-10 expression in 35% ± 21% of
NK cells. Sham-infected mice showed 0.5% ± 0.5% and 0.3% ±
0.1% GFP+ NK cells, respectively. These data suggested that
NK cell-derived IL-10 may be a common feature of the immune
response to multiple pathogens that rapidly disperse throughout
the host. To test whether systemic, sterile inflammation would
also elicit NK cell IL-10, we injected Vert-X mice i.v. with either
CpG or LPS. Indeed, systemic CpG triggered IL-10 expression
in 40% ± 8% of NK cells, and LPS elicited IL-10 in 42% ± 3%
of NK cells, compared to 0.2% ± 0.05% and 0.2% ± 0.07% in
mice given PBS (Figure 2B). Thus systemic inflammation ap-
peared sufficient to generate IL-10+ NK cells independently of
an initiating pathogen.Systemic Inflammation Elicits IL-10 in Pre-Existing,
Circulating NK Cells
Although mature NK cells typically emerge from the bone
marrow into the circulation, a recent study by Di Santo and
colleagues revealed a novel, thymic pathway of NK cell develop-
ment (Vosshenrich et al., 2006). Thymus-derived NK cells were
distinguished by their considerable cytokine production, a
feature they share with the CD56brightCD16neg NK cell subset in
humans that can produce significant amounts of IL-10 (Cooper
et al., 2001; Vosshenrich et al., 2006). In mice, thymus-derivedCell Host &NK cells are characterized by the expression of CD127, a marker
not found on NK cells developing in the bone marrow (Vosshen-
rich et al., 2006). Consistent with this observation, CD127+ NK
cells were readily detectable in the thymi of both naive mice
and those acutely infected with T. gondii but were infrequent in
other tissues (Figure 3A). However, GFP+ NK cells in T. gondii-
infected mice were exclusively CD127neg in all tissues, including
the thymus. Thus, IL-10+ NK cells appear to be bone marrow
derived and not to originate in the thymus.
While the absence of CD127 on IL-10+ NK cells suggested that
they originate in the bone marrow, it was not clear whether they
emerge as an inherently IL-10+ subset or whether pre-existing,
mature NK cells acquire IL-10 expression during toxoplasmosis.
To test this, blood-borne cells were surface biotinylated in vivo
prior to infection, by i.v. injection of a transiently reactive NHS-
biotin moiety (Mullarky et al., 2005). Seven days later, NK cells
were analyzed to assess their biotinylation, indicating their
presence in the blood before infection, and IL-10 expression
(Figure 3B). Of the biotinylated NK cells, 85% ± 6% initiated GFP
expression in response to T. gondii infection, whereas only 1% ±
0.04%of labeled NKcellsbecameGFP+ insham-infectedanimals.
The frequency and extent of IL-10 expression within the biotiny-
lated NKcells wereequivalent to those of their nonlabeledcounter-
parts in the same animal, demonstrating that the surface biotinyla-
tion did not interfere with IL-10 induction. Together these results
suggested that NK cells in the circulation prior to infection acquire
IL-10 expression during toxoplasmosis. To confirm this, we adop-
tively transferred blood-borne, GFP lymphocytes from naive
Vert-X mice into CD45 disparate hosts and infected the recipients
with T. gondii. Donor NK cells became 70% ± 5% GFP+ in T. gon-
dii-infected, but not sham-infected, hosts (2% ± 2%) (Figure 3C).
Together these results demonstrate that infection with T. gondii
induces IL-10 expression in mature, circulating NK cells.
Infection with T. gondiiwas also associated with an increase in
number of NK cells in the blood and liver (Figure 3D), suggesting
that the induction of IL-10 may be concurrent with cell prolifera-
tion. Indeed, NK cells in T. gondii-infected mice displayed an
activated phenotype with increased FSC profile, upregulation
of the acute activation marker CD69, and enhanced expression
of IFN-g as indicated by YFP fluorescence in Yeti reporter
mice (Mayer et al., 2005; Stetson et al., 2003) (Figure 3E). Given
that essentially all NK cells upregulate IFN-g (Figure 3E) and that
the bulk population is IL-10-GFP+ (Figures 1 and 2), the majority
of NK cells must express both cytokines. To determine whether
circulating NK cells proliferate upon infection, we adoptively
transferred CFSE-labeled PBL from naive CD45.2 donors into
naive CD45.1 hosts and infected the recipient mice with
T. gondii. As shown in Figure 3F, NK cells divided markedly in
T. gondii-infected but not sham-infected hosts, as revealed by
the loss of CFSE fluorescence. Taken together, these data
show that the induction of IL-10 in pre-existing, circulating NK
cells is associated with activation and extensive proliferation.
IL-12 Is Necessary and Sufficient to InduceNKCell IL-10
Systemic infections with both protozoa and bacteria generate
robust IL-12 responses in their host (Gazzinelli et al., 1994; Tripp
et al., 1994), and since IL-12 can elicit expression of IL-10 by NK
cells in vitro (Grant et al., 2008), we hypothesized that NK cell
IL-10 in vivo might also be driven by IL-12. Indeed, direct exMicrobe 6, 503–512, December 17, 2009 ª2009 Elsevier Inc. 505
Figure 3. Circulating NK Cells Initiate IL-10 Expression in Response
to Infection
(A) Vert-X mice were T. gondii or sham infected, and 7 days later, NK cells from
the indicated organs were analyzed by flow cytometry. Numbers indicate the
percentage of cells within quadrants and were rounded to full digits.
(B) Vert-X mice were injected i.v. with NHS-biotin in DMSO, or with DMSO
alone, and infected with T. gondii 12 hr later. On day 7, PBLs were stained
with streptavidin and analyzed by flow cytometry. Data are gated on NK cells.
(C) PBL from naive, CD45.1+ Vert-X mice were transferred i.v. into CD45.2+
C57BL/6 mice 12 hr before T. gondii infection. PBL from recipient mice were
harvested 7 days later and GFP expression quantified in NK cells from both
the transferred (Vert-X) and host (C57BL/6 nonreporter) populations.
(D) C57BL/6 mice were infected with T. gondii and NK cells enumerated in the
indicated organs 7 days later. Error bars indicate SD from four mice per group.
(E) Mice were infected as in (C), and blood-borne NK cells were analyzed by
flow cytometry for forward scatter and CD69. Yeti IFN-g-reporter mice were
similarly infected and blood-borne NK cells assessed for YFP expression.
(F) PBL from naive, CD45.2+ C57BL/6 mice were labeled with CFSE and trans-
ferred i.v. into congenic CD45.1+ mice 12 hr before T. gondii infection. PBL
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506 Cell Host & Microbe 6, 503–512, December 17, 2009 ª2009 Elsevivo analysis 5 days after infection with T. gondii revealed that
STAT4, the signaling adaptor of the IL-12/23 receptor complex,
was phosphorylated in virtually all NK1.1+ cells, demonstrating
actively engaged signaling (Figure 4A) (Wu et al., 2000). This
in vivo activation of STAT4 was IL-12p40 dependent, because
it was completely abolished by the administration of a neutral-
izing anti-IL-12p40 antibody (Figure 4A). To test whether IL-
12p40 was necessary for the induction of NK cell IL-10, Vert-X
mice were treated with anti-IL-12p40 during T. gondii infection
and analyzed after 1 week. Neutralization of IL-12p40 abrogated
the induction of IL-10 in NK cells (only 5% ± 2% of blood NK cells
were GFP+ in anti-p40 treated mice, compared to 81% ± 7% in
isotype-treated controls) (Figure 4B). Because the IL-12p40
subunit is shared by IL-12 and IL-23 (Hunter, 2005), these exper-
iments did not discriminate which of these cytokines is required
to induce NK cell IL-10. We therefore analyzed IL-12Rb2-defi-
cient NK cells, which are selectively nonresponsive to IL-12
(Wu et al., 2000). To distinguish direct effects of IL-12 on NK cells
from global abnormalities caused by the complete absence
of IL-12 responsiveness, we generated mixed bone marrow
chimeras reconstituted with equal parts of IL-12Rb2/ and
CD45.1 congenic WT bone marrow. T. gondii-infected chimeras
displayed STAT4 phosphorylation in WT but not IL-12Rb2/ NK
cells (Figure 4C), demonstrating both that IL-12 signaling was
selectively disrupted and that no other cytokine triggered the
phosphorylation of STAT4 in IL-12Rb2/ cells. Importantly, in
contrast to the WT cells sorted from the same T. gondii-infected
animal, IL-12Rb2/ NK cells failed to induce IL-10 (Figure 4D).
These data show in vivo that direct IL-12 signals are necessary
for the induction of IL-10 in NK cells.
To test whether IL-12 is also sufficient to elicit NK cell-derived
IL-10, lymphocytes from naive Vert-X mice were cultured with
IL-2 in the absence or presence of IL-12 (Figure 4E). The addition
of IL-12 alone was sufficient to induce the expression of IL-10 in
NK cells, and NK cells sorted from naive C57BL/6 mice released
significant amounts of IL-10 only when stimulated by the addition
of IL-12 (Figure 4F), a finding consistent with recently published
data (Grant et al., 2008). Moreover, systemic i.v. administration
of recombinant IL-12 to naive Vert-X mice efficiently triggered
IL-10 expression in NK cells (70% ± 3% of blood NK cells
became GFP+, compared to 0.3% ± 0.04% in PBS controls) (Fig-
ure 4G). Together these data formally demonstrate that direct
IL-12 signals are both necessary and sufficient to induce NK cells
to produce IL-10 in vivo.
NK Cell IL-10 Inhibits IL-12 Production by DC
Since the anti-inflammatory action of IL-10 is thought to be
largely mediated by its ability to inhibit the production of IL-12
by antigen-presenting cells (Moore et al., 2001), these data sug-
gested that a negative feedback loop could exist in which IL-12
limits its own production by eliciting IL-10 from NK cells. Indeed,
when NK cells were isolated from T. gondii-infected C57BL/6
mice and mixed with LPS-stimulated, IL-10/ DCs, such that
the only potential source of IL-10 in these cultures was the NK
cells, their net effect was to significantly inhibit IL-12 productionwere harvested and CFSE dilution analyzed within the NK cell population
7 days later. All panels are representative of at least two independent experi-
ments with three to four mice per group; *p < 0.05.
vier Inc.
Figure 4. IL-12 Is Necessary and Sufficient
to Elicit IL-10 Production by NK Cells
(A) C57BL/6 mice received anti-IL-12p40 or an
isotye mAb on days 1 and 3 and were T. gondii
or sham-infected on day 0. On day 4, PBL were
stained directly ex vivo for NK1.1 and phosphory-
lated Stat4. Horizontal guidelines indicate the
mode fluorescence intensity of pStat4 staining in
sham-infected animals.
(B) Vert-X mice were treated as in (A). NK cells in
the blood were analyzed for GFP on day 7.
(C) Mixed bone marrow chimeras were generated
by reconstituting of CD45.1+ recipients with equal
parts of CD45.1+ WT and CD45.2+ IL-12Rb2/
BM. Reconstituted mice were T. gondii or sham
infected, and 4 days later PBLs were stained as
in (A).
(D) WT and IL-12Rb2/ NK cells from the blood
and liver of infected chimeras were FACS sorted on day 7 and analyzed for IL-10 by RT-PCR. Transcript levels in WT cells were set to 1.
(E) PBLs from naive Vert-X mice were cultured for 48 hr in the presence of IL-2 alone or IL-2 and IL-12. GFP expression by NK cells was determined by flow
cytometry.
(F) NK cells were FACS sorted from the livers of C57BL/6 mice and cultured as in (E). Culture supernatants were harvested 48 hr later and analyzed for IL-10
protein. Error bars indicate SD of triplicate cultures.
(G) Naive Vert-X mice were injected with recombinant IL-12 i.v., and blood was analyzed 48 hr later. Data are gated on NK cells. All panels are representative of
three to five mice per group and at least two independent experiments.
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IL-10, since the inclusion of an IL-10R-blocking antibody instead
enabled the NK cells to strongly potentiate IL-12 release
(Figure 5A). Interestingly, NK cell-derived IL-10 was functional
even at a concentration undetectable in the culture superna-
tants; it became directly measurable only when cytokine con-
sumption was prevented by the IL-10R-blocking antibody.
Considerable quantities of IFN-g were also detected in the
cocultures, particularly when LPS was used to trigger DC-
derived IL-12 and thereby augment NK stimulation (Figure 5A).
These results suggest that activated NK cells release both
IL-10 and IFN-g, and that the selective inhibition of only IL-10
enables the remaining IFN-g to enhance DC activation. Together
these data reveal that the net function of IL-10+ NK cells is to limit
DC release of proinflammatory IL-12.
To test whether NK cells exhibit the same immunosuppressive
activity in vivo during systemic infection, we depleted NK cells
during acute toxoplasmosis in C57BL/6 mice. Indeed, NK cell-
depleted animals showed significantly higher concentrations of
serum IL-12 compared with isotype-treated controls (Figure 5B),
suggesting that NK cells can act to inhibit infection-induced
systemic inflammation. Their immunosuppressive function ap-
peared similarly effective to that of CD4+ T cells, since the
depletion of either population led to equivalent increases in
serum IL-12 and IFN-g in T. gondii-infected mice (Figure S3).
Neither NK nor CD4+ T cells, when singly depleted, could reca-
pitulate the blockade of IL-10 function achieved by treatment
with an anti-IL-10R antibody (Figure S3), and together these
data suggest that, while neither population is the only source,
both NK cells and CD4+ T cells contribute IL-10 to the immune
response elicited by T. gondii infection.
NK Cell IL-10 Is Triggered by Systemic
Availability of IL-12
Our earlier experiments indicated that NK cell-derived IL-10 was
driven by systemic inflammation associated with diverse, rapidlyCell Host &disseminating pathogens. To investigate whether localized
infection would also elicit NK cell IL-10, we challenged Vert-X
mice with the respiratory influenza virus. In contrast to the
systemic pathogens T. gondii and Y. pestis, influenza virus did
not induce IL-10 expression in NK cells (Figure 6A). This was
true in both the blood and the infected tissues (BAL and lung),
at days 3, 5, and 10 after infection and at infectious doses ranging
from 300 to 30,000 EID50 (Figure 6A and data not shown). One
possible explanation for these data is that, in contrast to
systemic inflammation, local infection does not elicit sufficient
IL-12 to induce NK cell IL-10. This hypothesis was consistent
with the absence of ex vivo STAT4 phosphorylation in NK cells
during influenza virus infection (Figure 6B). To test whether
increased availability of IL-12 could initiate NK cell expression
of IL-10, we infected Vert-X mice with influenza virus and,
5 days later, injected rIL-12 i.v. As expected (Figure 4G), this
treatment resulted in phosphorylation of STAT4 in essentially
all NK cells in both the blood and BAL, at an equivalent level to
that achieved by rIL-12 administered to naive mice (Figure 6B).
Importantly, the injection of IL-12 into influenza virus-infected
mice also triggered IL-10 expression by NK cells in all tissues
examined, including the blood, BAL, and lung (82% ± 3% of
NK cells in the blood, 70% ± 8% in the BAL, and 75% ± 3% in
lung were GFP+ after rIL-12 injection, compared to 0.3% ±
0.04%, 1.0% ± 0.3%, and 0.2% ± 0.1% in infected mice given
PBS) (Figure 6C). These data show that, during infection with
influenza virus, NK cells retain the capacity to express IL-10 in
response to IL-12 and will do so when sufficient IL-12 is available.
To confirm that the absence of IL-12-driven IL-10 expression
in NK cells during influenza was due to the local containment
of infection rather than a unique feature of viral pathogens,
we sought an experimental system in which the same microbe
could be used in either a local or a systemic challenge. In
contrast to the parental wild-type Y. pestis, the attenuated
Kim10+caf1 strain (Philipovskiy and Smiley, 2007) fails to
disseminate from the lung when inoculated i.n. but establishesMicrobe 6, 503–512, December 17, 2009 ª2009 Elsevier Inc. 507
Figure 5. NK Cell IL-10 Limits IL-12 Production by DC
(A) Wild-type NK cells were sorted from the livers of C57BL/6 mice infected
with T. gondii 7 days earlier and cultured with IL-10/ DCs. LPS and either
anti-IL-10R or an isotype control antibody were included as indicated. Culture
supernatants were harvested after 16 hr and analyzed by cytometric bead
array. Error bars indicate SD of triplicate cultures.
(B) C57BL/6 mice received anti-NK1.1 or an isotype mAb on days 1 and 3
and were T. gondii or sham infected on day 0. Serum was collected on day
5 and analyzed for IL-12 by cytometric bead array. Both panels are represen-
tative of two independent experiments; *p < 0.001.
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infection with this attenuated Y. pestis did not engage STAT4
signaling in circulating NK cells, whereas systemic administra-
tion of an identical dose of the same attenuated bacterium stim-
ulated robust STAT4 phosphorylation in the bulk NK cell popula-
tion (Figure 6E). Moreover, i.n. infection did not elicit IL-10 in NK
cells, even in the lung, and despite a locally equivalent bacterial
burden to that achieved by disseminated infection following i.v.
challenge (0.3% ± 0.1% of lung NK cells and 0.2% ± 0.1% in
the liver were GFP+ 4 days after i.n. inoculation, compared to
59% ± 2% and 53% ± 2% after systemic delivery; Figure 6F).
The lack of NK cell-derived IL-10 reflected the localized infection
rather than the intranasal route of pathogen encounter, since the508 Cell Host & Microbe 6, 503–512, December 17, 2009 ª2009 Elserapidly disseminating, parental Y. pestis strain did induce IL-10
expression in NK cells after i.n. delivery (Figure 6A). Together
these results suggest that the levels of IL-12 that induce NK
cell-derived IL-10 are a unique feature of systemic infection,
demonstrating that the dissemination of a pathogen can change
the cellular and cytokine composition of the host response.
DISCUSSION
IL-10 has a critical role in dampening immune responses and
preventing immunopathology, largely due to its ability to mitigate
IL-12 (Anderson et al., 2007; Belkaid, 2007; Corinti et al., 2001;
Gazzinelli et al., 1996; Jankovic et al., 2007; Suzuki et al.,
2000). In this study we have identified NK cells as important
mediators of this regulatory circuit: during disseminated infec-
tions, NK cells rapidly express IL-10 in response to systemic
IL-12 and thereby limit further production of IL-12. The release
of IL-10 by NK cells has been previously observed in vitro (Grant
et al., 2008; Mehrotra et al., 1998) and, recently, during the late
stages of murine visceral leishmaniasis (Maroof et al., 2008). In
contrast, we demonstrate here that IL-10+ NK cells are an early
and dominant feature of acute systemic inflammatory responses
but are not elicited by localized infections with influenza virus or
a Y. pestis bacterium attenuated to prevent its dissemination
from the site of infection. The activation of an NK cell-mediated
immunosuppressive loop therefore appears to be a unique
characteristic of systemic inflammation, and we propose that
NK cells provide rapid and widespread IL-10 release to counter
situations of dangerous escalation in proinflammatory cytokines.
Expression of IL-10 by NK cells was triggered in vivo by three
rapidly disseminating pathogens, T. gondii, L. monocytogenes,
andY. pestis. The acute, systemic inflammatory response gener-
ated by these infections is characteristic of sepsis, where the
balance between IL-10 and IL-12 can be critical for survival
(Jansen et al., 1996). NK cells have been reported to exacerbate
disease in some murine models of sepsis (Barkhausen et al.,
2008; Etogo et al., 2008), an effect attributed to their production
of IFN-g. However, there is also evidence that transgenic expres-
sion of IL-15, a NK cell-growth factor, protects mice from septic
shock (Hiromatsu et al., 2003). Our data suggest that NK cells
can simultaneously express both IFN-g and IL-10 (Figures 1, 3,
and 5; Chakir et al., 2001), and, while other reports have illus-
trated the ability of NK cells from naive mice to potentiate
a Th1 response (Goldszmid et al., 2007; Guan et al., 2007;
Martin-Fontecha et al., 2004), our data demonstrate that during
acute systemic infection, the net outcome of the coproduction
of IL-10 and IFN-g by NK cells is immune regulation (Figure 5).
The concurrent expression of both IFN-g and IL-10 by NK cells
parallels that of highly activated Th1 cells (Anderson et al.,
2007; Jankovic et al., 2007), and indeed the production of
IL-10 by human NK cell clones has also been proposed to be
a late stage of terminal differentiation (Loza and Perussia, 2001).
One of the most striking findings in our study is the majority of
NK cells that rapidly express IL-10 during systemic inflammation.
We show that IL-10 expression is initiated in pre-existing, circu-
lating NK cells and that direct IL-12 signals are both necessary
and sufficient for its induction. This extends a recent report that
IL-12 can initiate the production of IL-10 by murine NK cells
cultured in vitro (Grant et al., 2008). Intriguingly, IL-12 isvier Inc.
Figure 6. NK Cell IL-10 Is Elicited by Systemic but Not Local Inflam-
mation
(A) Vert-X mice were infected withT. gondii,Y. pestis, or influenza virus and ana-
lyzed by flow cytometry 7, 4, and 5 days later, respectively, together with sham-
infected controls. Data shown are gated on NK cells from the indicated organs.
(B) C57BL/6 mice were either sham infected or infected with influenza virus i.n.
and, 5 days later, BAL cells and PBL stained directly ex vivo for NK1.1 and
phosphorylated Stat4. Some mice received recombinant IL-12 by i.v. injection
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Cell Host &paramount in driving Th1-polarized immune responses (Gazzinelli
et al., 1994; Magram et al., 1996), and yet localized, respiratory
infectionwith the influenzavirus did notelicit NK cell IL-10, despite
clear Th1 induction (Mayer et al., 2005). NK cells were not refrac-
tory to IL-12 stimulation during influenza infection, and indeed
systemic administration of exogenous IL-12 elicited IL-10+ NK
cells even in the context of viral infection (Figure 6). This might
suggest that the concentration of IL-12 induced by influenza
infection, although sufficient to polarize a Th1 response, remains
below a threshold required to activate NK cell IL-10 expression.
Alternatively, the location of IL-12 released during influenza may
be tightly controlled, perhaps restricted to the synapse between
APC and cognate T cell, and thus inaccessible to NK cells.
Direct interactions between NK cells and DC have been
described both within the lymph node (Bajenoff et al., 2006)
and in peripheral tissues (Moretta, 2002). The distribution of
IL-10+ NK cells in predominantly nonlymphoid tissues (Figure 1B)
positions them at a site where DC can be conditioned prior to
their migration into the lymph node. IL-10 has potent effects on
both DC and macrophages, inhibiting their expression of MHC
and costimulatory molecules and suppressing their production
of proinflammatory cytokines including IL-12 (Figure 5)
(Li and Flavell, 2008; Moore et al., 2001), but the impact of IL-10
weakens as the APCs mature (Moore et al., 2001; Perona-Wright
et al., 2007). Thus the localization and kinetics of the NK cell
IL-10 response grant these cells the potential to influence the
adaptive immune response from the point of its initiation. This
timescale may be particularly important in sepsis, where fatality
can precede the adaptive immune response (Cohen, 2002).
The dominance of the IL-10+ phenotype within the NK popula-
tion differs from the lower frequency within T cell subsets (Fig-
ure 1A) and presumably reflects the ability of NK cells to respond
to cytokine alone, whereas T cells also require recognition of
cognate antigen. A recent report demonstrated that WT CD4+
T cells were sufficient to rescue Rag/IL-10/ mice from lethal
toxoplasmosis (Jankovic et al., 2007); in contrast, we reveal here
that NK cells are a prominent source of IL-10 in immunologically
intact animals, providing IL-10 before antigen-specific sources
are available. Multiple cell types express IL-10 during immune-
driven inflammatory responses (Figure 1A, Figure S3; Moore
et al., 2001). The contribution of each one reflects both their
distinct temporal and spatial distributions and the different
stimuli that elicit their IL-10. Given the active engagement of
the IL-12/STAT4 pathway in essentially all circulating NK cells2 hr before sacrifice. Horizontal guidelines indicate the mode fluorescence
intensity of pStat4 staining in PBL and BAL lymphocytes from sham-infected
animals, respectively.
(C) Vert-X mice were either sham infected or infected with influenza virus and,
3 days later, injected i.v. with either PBS or recombinant IL-12. Cells were
analyzedbyflowcytometry aftera further48hr.DatashownaregatedonNKcells.
(D) Vert-X mice were infected with 33 106 CFU of the attenuated Kim10+caf1
strain of Y. pestis by either i.n. or i.v. administration. Four days later, the indi-
cated organs were ground and plated to assess bacterial burden. Dashed
line denotes limit of detection.
(E) C57BL/6 mice were infected as in (D) and 2 days later, PBL were stained
directly ex vivo for NK1.1 and phosphorylated Stat4, as in (B).
(F) Vert-X mice were infected as in (D) and analyzed by flow cytometry 4 days
later. Data in all panels are representative of three to five mice per group in at
least two independent experiments.
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ciency of IL-12 signals alone to trigger the release of IL-10
protein (Figure 4F), it is likely that the majority of GFP+ NK cells
that we observe are secreting IL-10 in vivo. The activation of
the IL-12/STAT4 pathway for the induction of NK cell-derived
IL-10 is conserved between humans and mice, because IL-12
also triggers the production of IL-10 by purified human NK cells
in vitro (Akuffo et al., 1999; Cooper et al., 2001; Mehrotra
et al., 1998; Peritt et al., 1998). Indeed, a STAT4-binding site,
CNS+3.10, was recently identified in the il10 gene and is con-
served between these species (Grant et al., 2008). Septic
patients often exhibit simultaneously increased plasma concen-
trations of IL-10 and IL-12, a finding that has been proposed as
a diagnostic criterion (Sherwin et al., 2008).
Therapeutically, the ability of IL-12 to elicit IL-10 from NK cells
has additional consequence, suggesting that the administration
of IL-12 or inflammatory adjuvants could counterintuitively elicit
immunosuppression. Indeed, IL-12-treated cancer patients
have been reported to display elevated serum IL-10 levels (Por-
tielje et al., 2003). Collectively these findings underscore the clin-
ical importance of understanding the IL-12:IL-10 balance. Here
we have shown that NK cells are a rapidly available and abun-
dant source of IL-10 upon IL-12 stimulation, thus defining
a mechanism of immune regulation uniquely activated by acute,
systemic inflammatory disease.
EXPERIMENTAL PROCEDURES
Mice
Vert-X (C57BL/6 IL-10/eGFP) mice (Madan et al., 2009), Yeti (C57BL/6 IFN-g-
eYFP) (Stetson et al., 2003), C57BL/6, CD45.1+ congenic (B6.SJL-Ptprca-
Pep3b/BoyJ), C57BL/6xRag2/ (Shinkai et al., 1992), IL-12Rb2/
(B6.129S1-Il12rb2tm1Jm/J), and IL-10/ (B6.129P2-Il10tm1Cgn/J) mice were
bred and housed in the animal facility of the Trudeau Institute. Animals
were kept under specific pathogen-free conditions in filter-top cages and
were used at 6–12 weeks of age. All experimental procedures were approved
by the Institutional Animal Care and Use Committee.
Mixed Bone Marrow Chimeras
CD45.1+ C57BL/6 mice were lethally irradiated (950 rads) and reconstituted
with 1 3 107 bone marrow cells, comprising equal parts CD45.1+ WT and
CD45.2+ IL-12Rb2/ bone marrow. Chimeras were allowed to reconstitute
for 6–8 weeks before infection.
Infections, TLR Challenge, and IL-12 Administration
Mice were infected with ten cysts of ME49 Toxoplasma gondii by gavage, 13
105 CFU Listeria monocytogenes (strain EGD) by i.p. injection, 2 3 105 CFU
Yersinia pestis (strain KIM D27) by i.n. instillation, or 300 EID50 of the A/HK-
x31 (x31, H3N2) influenza A virus i.n., as described previously (Johnson
et al., 2003; Mayer et al., 2005; Mullarky et al., 2005; Parent et al., 2005).
The attenuated Yersinia pestis strain Kim10+caf1 (Philipovskiy and Smiley,
2007) was injected either i.n. or i.v., as indicated, at a dose of 3 3 106 CFU
per mouse. In T. gondii experiments, sham-infected control animals were
administered uninfected brain. In other experiments, control animals received
PBS by the appropriate route. T. gondii-infected mice were analyzed 7 days
postinfection; those infected withL.monocytogenes orY. pestiswere analyzed
on day 4. Both CpG (ODN1826 [InvivoGen]) and LPS (from E. coli B4:111
[Sigma]) were administered i.v. at a dose of 50 mg/mouse, and recombinant
mouse IL-12p70 (PeproTech) was injected i.v. at a dose of 1 mg/mouse.
Controls received PBS alone, and mice were analyzed 48 hr postinjection.
Tissue Sampling and Flow Cytometry
Single-cell suspensions were prepared from blood, spleen, mesenteric LN,
bone marrow, and thymus by mechanical disruption and red cell lysis, where510 Cell Host & Microbe 6, 503–512, December 17, 2009 ª2009 Elseneeded. Liver lymphocytes, lungs, and brains were perfused, digested for
40 min with collagenase IV (100 U/ml) and DNaseI (10 U/ml), and lymphocytes
enriched at the interphase of a discontinuous 60/40 Percoll gradient. The
following mAbs were used for flow cytometry: CD33 (clone 145-2C11), CD4
(RM4-5), CD8a (53-6.7), CD11c (HL3), CD19 (ID3), CD45.1 (A20), CD45.2
(104), CD69 (H1.273), CD127 (A7R34), I-Ab (28-16-8S), NK1.1 (PK136), and
TCRb (H57-597). NK cells were identified as NK1.1+ and either CD3 or
TCRb. Intracellular staining for phopshorylated STAT4 was performed on
PBL or BAL cells immediately after red cell lysis using PhosFlow reagents
(BD Biosciences) according to the manufacturer’s instructions.
In Vivo Biotinylation
Labeling of circulating lymphocytes was achieved by intravenous injection of
1.2 mg of sulfo-N-hydroxysuccinimide-biotin (Calbiochem) dissolved in 10%
DMSO and given as two doses separated by 2 hr (Mullarky et al., 2005).
Mice were infected 12 hr later, and biotinylated cells were identified by staining
with streptavidin-PE.
In Vivo Cytokine Neutralization
Cytokine depletion in vivo was achieved by i.p. administration of 0.75 mg per
mouse of rat anti-mouse IL-12/23 p40 antibody (clone C17.8,), anti-IL-10R
antibody (clone 1B1.3A), or an IgG isotype control (HPRN), 12 hr before and
3 days after infection.
Cell Transfer
Peripheral blood lymphocytes were harvested from naive CD45.1+ Vert-X or
CD45.2+ C57BL/6 mice, and 2–3 3 106 cells were transferred i.v. into CD45
disparate WT hosts. Recipients were infected 12 hr later. Where indicated,
cells were labeled with CFSE (3 mM) for 10 min at 37C prior to transfer.
Cell Sorting, In Vitro Activation, and Cytokine Quantification
NK cells were purified from T. gondii- or sham-infected livers using a FACS-
Vantage cell sorter. Resultant cells were >95% NK1.1+TCRb and were
used immediately for RNA extraction and RT-PCR, or cultured for 48 hr
at 1 3 106/ml in the presence of IL-2 (300 U/ml), IL-2 and IL-12 (5 ng/ml),
or phorbol 12-myristate 13-acetate (PMA, 50 ng/ml) and ionomycin (1 mM).
Cytokines in culture supernatants were quantified with the Mouse Inflamma-
tion Cytometric Bead Array kit (BD PharMingen) according to the manufac-
turer’s instructions. Unfractionated PBLs from naive Vert-X mice were similarly
cultured with IL-2 ± IL-12 and their GFP expression measured 48 hr later by
FACS, as detailed above.
RT-PCR
RNA extraction and quantitative real-time RT-PCR were performed as
described (Johnson et al., 2003; Mohrs et al., 2005).
Dendritic Cell and NK Cell Coculture
DCs were generated from IL-10/ BM in the presence of recombinant GM-
CSF (Peprotech), as described (MacDonald et al., 2001), and were >90%
CD11c+MHCII+. DCs were harvested on day 10 of culture and replated at
1 3 106 DC/ml in the presence or absence of LPS (100 ng/ml, from E.coli
011:B4, Sigma), an equal number of NK cells sort-purified from T. gondii-
infected livers (see above), anti-IL10R antibody (40 mg/ml, clone 1B1.3A), or
a rat IgG isotype control (HPRN). Culture supernatants were collected at
16 hr and cytokines measured by cytometric bead array, as above.
In Vivo Cell Depletions
Discrete cell populations were depleted in vivo by i.p. administration of
0.75 mg per mouse of rat anti-mouse NK1.1 antibody (clone PK136), anti-
CD4 (clone Gk1.5), or an IgG isotype control (HPRN), 12 hr before and
3 days after T. gondii infection. Serum was collected on day 5 and cytokines
measured by cytometric bead array, as above.
Statistical Analysis
All data are presented as the means ±SD unless otherwise indicated. Numer-
ical data were analyzed for statistical significance using Student’s unpaired
t test with Prism software (GraphPad). P values < 0.05 were considered statis-
tically significant.vier Inc.
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